Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 188 of 1,261
  1. US 11680249

    Adeno-associated virus capsid variants and methods of use thereof

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  2. US 11680105

    Antibody fragments for detecting cancer and methods of use

    Regents of the University of Minnesota · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  3. US 11680254

    Engineered meganucleases specific for recognition sequences in the PCSK9 gene

    Precision BioSciences, Inc. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  4. KR 20230088753

    파킨슨병 치료를 위한 오피카폰 및 레보도파

    BIAL PORTELA & CA SA [PT] · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  5. US 11680079

    Nucleic acid aptamers to treat histone-induced disease states

    The United States Government as Represented by The Department of Veteran Affairs · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  6. US 11680093

    Monoclonal antibodies that specifically bind to matrilin 3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  7. US 11680244

    Method for generating human dendritic cells for immunotherapy

    The Regents of the University of California · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  8. US 11680090

    Interleukin-2 fusion proteins and uses thereof

    Medicenna Therapeutics Inc. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  9. US 11680070

    Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof

    Medshine Discovery Inc. · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  10. US 11680067

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Jun 20, 2023 · Expires Jun 15, 2043

    granted
  11. US 11672762

    Onapristone extended-release compositions and methods

    CONTEXT BIOPHARMA, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  12. US 11672813

    Bortezomib compositions

    MAIA PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  13. US 11672872

    Anti-transferrin receptor antibody and uses thereof

    Dyne Therapeutics, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  14. US 11672831

    Use of adipose tissue-derived stromal stem cells in treating fistula

    Takeda Pharmaceutical Company Limited · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  15. US 11672811

    Materials and methods for suppressing and/or treating bone related diseases and symptoms

    The United States of America as Represented by the Department of Veteranas Affairs · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  16. US 11672794

    Therapeutic targeting of the BAP1 complex in cancer

    Northwestern University · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  17. US 11673930

    IL10 agonists and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  18. US 11672793

    Compositions of CXCR4 inhibitors and methods of preparation and use

    X4 Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  19. US 11673879

    Substituted pyrimidines and methods of use

    Theravance Biopharma R&D IP, LLC · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  20. US 11672785

    Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

    Olema Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  21. US 11672791

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  22. US 11672775

    Treprostinil prodrugs

    United Therapeutics Corporation · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  23. US 11672776

    Multi-arm polymeric alkanoate conjugates

    Nektar Therapeutics · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted
  24. US 11673860

    Crystalline siponimod fumaric acid and polymorphs thereof

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 13, 2023 · Expires Jun 8, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.